Riskpilot← Back to searchSign inGet full accessBroadview Life Sciences AB
ABActiveOrg 5564826187Klubbans Väg 19Retail sale of other food · NACE 4727Est. 19945-9 employees
Revenue 2024
SEK 4,3M
+11% vs 2023
EBITDA margin
16.1%
+221% vs 2023
Equity ratio
74.7%
Financial strength
Net profit 2024
SEK 14K
+27% vs 2023
| Revenue | SEK 4,3M | +11% |
| EBITDA | SEK 700K | +221% |
| Net profit | SEK 14K | +27% |
| Total assets | SEK 4,3M | +3% |
| Equity | SEK 3,2M | +0% |
| Employees | — | — |
Legal name
Broadview Life Sciences AB
Org number
5564826187
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
28 februari 1994
Share capital
SEK 1 000 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva försäljning av livsmedel, nutritionsprodukter, kosttillskott samt hud-, hår- och andra kroppsvårdsprodukter, rengöringsmedel och vattenreningsprodukter samt därmed förenlig verksamhet.
Address
Klubbans Väg 19
Phone
+4631674000
Email
magnus.ahlen@thebroccoli.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 6 203 | 7 328 | 6 304 | 5 889 | 5 714 | 5 182 | 3 927 | 4 346 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 534 | −61 | 3 323 | 2 357 | 914 | 503 | 554 | 276 | 218 | 700 |
| Depreciation & amort. | −6 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 528 | −61 | 3 323 | 2 357 | 914 | 503 | 554 | 276 | 218 | 700 |
| Net financials | −12 | −2 | — | −3 | 2 | — | — | 1 | 16 | 35 |
| Profit before tax | 116 | 337 | −387 | 855 | 66 | 53 | 55 | 26 | 14 | 15 |
| Tax | −0 | −0 | −0 | −18 | −28 | −12 | −15 | −6 | −3 | −1 |
| Net profit | 116 | 337 | −387 | 837 | 38 | 41 | 40 | 20 | 11 | 14 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 499 | 2 883 | 2 890 | 3 909 | 4 017 | 4 752 | 4 263 | 3 878 | 4 124 | 4 258 |
| Equity | 2 230 | 2 567 | 2 180 | 3 016 | 3 054 | 3 095 | 3 135 | 3 155 | 3 166 | 3 180 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 269 | 316 | 710 | 893 | 963 | 1 657 | 1 128 | 722 | 957 | 1 078 |
| Total debt | 269 | 316 | 710 | 893 | 963 | 1 657 | 1 128 | 722 | 957 | 1 078 |
EBITDA margin
16.1%
This company
15.8%
Market median
+2% vs market
20152024
Equity ratio
74.7%
This company
38.2%
Market median
+96% vs market
20152024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20152024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20152024
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20152024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK Audit | Audit | 2022 | — | — |
PC Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Broadview Charter AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Broadview Charter AB
Broadview Life Sciences AB Board members of Broadview Life Sciences AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ado Korda | Audit | 0 companies |
| Pia Christina Haller | Audit | 0 companies |
| Erik Magnus Ahlén | Board of Directors | 0 companies |
| Jenny Margareta Emilia Boström | Deputy Board Member | 0 companies |
| Karin Agneta Elmsved Ahlén | Deputy Board Member | 0 companies |